Neurológia pre prax 3/2018
Súčasné možnosti dlhodobej liečby roztrúsenej sklerózy: výhody a nevýhody perorálnej liečby roztrúsenej sklerózy
The current long-term treatment of multiple sclerosis: the advantages and disadvantages of oral treatment Nowadays, there is increasng possibilities of DMD (disease-modifying drugs) in treatment of multiple sclerosis (MS). There were available only parenteral therapy in the past. Now, there are available also oral forms of DMD therapy. This is teriflunomide from first line DMD therapy and fingolimod and dimetfyl fumarate from second line therapy. These oral forms also have any advantages and disadvantages so as parenteral forms.
Keywords: DMD therapy, oral forms, teriflunomidem dimethyl fumarate, fingolimod












